Analysis_NN
of_IN
the_DT
modulation_NN
of_IN
transcriptional_JJ
activity_NN
in_IN
myelopoiesis_NN
and_CC
leukemogenesis_NN
._.

Acute_JJ
myeloid_JJ
leukemia_NN
-LRB-_-LRB-
AML_NN
-RRB-_-RRB-
is_VBZ
still_RB
associated_VBN
with_IN
a_DT
mortality_NN
of_IN
60_CD
to_TO
80_CD
%_NN
._.

AML_NN
is_VBZ
characterized_VBN
by_IN
a_DT
block_NN
in_IN
myeloid_JJ
differentiation_NN
._.

The_DT
transcription_NN
factors_NNS
PU_NN
.1_CD
and_CC
C\/EBPalpha_NN
are_VBP
responsible_JJ
for_IN
normal_JJ
myeloid_JJ
differentiation_NN
from_IN
stem_NN
cells_NNS
to_TO
monocytes_NNS
or_CC
granulocytes_NNS
._.

In_IN
particular_JJ
,_,
PU_NN
.1_CD
induces_VBZ
expression_NN
of_IN
the_DT
macrophage_NN
colony-stimulating_JJ
factor_NN
-LRB-_-LRB-
M-CSF_NN
-RRB-_-RRB-
receptor_NN
and_CC
the_DT
development_NN
of_IN
monocytes_NNS
,_,
whereas_IN
C\/EBPalpha_NN
increases_VBZ
the_DT
expression_NN
of_IN
the_DT
granulocyte_NN
colony-stimulating_JJ
factor_NN
-LRB-_-LRB-
G-CSF_NN
-RRB-_-RRB-
receptor_NN
and_CC
leads_VBZ
to_TO
mature_JJ
granulocytes_NNS
._.

In_IN
AML_NN
,_,
chromosomal_JJ
aberrations_NNS
result_VBP
in_IN
oncoproteins_NNS
such_JJ
as_IN
AML1\/ETO_NN
,_,
PML\/RARalpha_NN
,_,
or_CC
activated_JJ
Ras_NN
,_,
which_WDT
can_MD
deregulate_VB
genes_NNS
important_JJ
for_IN
normal_JJ
myelopoiesis_NN
._.

Thus_RB
,_,
AML1\/ETO_NN
can_MD
bind_VB
to_TO
the_DT
transcription_NN
factor_NN
C\/EBPalpha_NN
,_,
inhibit_VB
C\/EBPalpha-dependent_JJ
transcription_NN
,_,
and_CC
block_VB
granulocytic_JJ
differentiation_NN
._.

However_RB
,_,
AML1\/ETO_NN
can_MD
also_RB
synergize_VB
with_IN
the_DT
transcription_NN
factor_NN
AML1_NN
to_TO
enhance_VB
the_DT
activity_NN
of_IN
the_DT
M-CSF_NN
receptor_NN
promoter_NN
._.

On_IN
the_DT
other_JJ
hand_NN
,_,
the_DT
PML\/RARalpha_NN
fusion_NN
protein_NN
causes_VBZ
transcriptional_JJ
repression_NN
by_IN
recruiting_VBG
the_DT
nuclear_JJ
corepressor_NN
-LRB-_-LRB-
N-CoR_NN
-RRB-_-RRB-
histone_NN
deacetylase_NN
complex_NN
to_TO
the_DT
DNA_NN
,_,
which_WDT
results_VBZ
in_IN
decreased_VBN
histone_NN
acetylation_NN
and_CC
a_DT
repressive_JJ
chromatin_NN
organization_NN
._.

Here_RB
we_PRP
describe_VBP
methods_NNS
to_TO
investigate_VB
whether_IN
and_CC
how_WRB
signaling_NN
agonists_NNS
induce_VBP
myeloid_JJ
differentiation_NN
and_CC
how_WRB
oncoproteins_NNS
might_MD
cause_VB
AML_NN
by_IN
modulating_VBG
the_DT
activity_NN
of_IN
transcription_NN
factors_NNS
that_WDT
are_VBP
pivotal_JJ
for_IN
normal_JJ
myeloid_JJ
development_NN
._.

Copyright_NN
1999_CD
Academic_NNP
Press_NNP
._.

